Table 2.

Definition of indicators ovarian carcinoma (numerator, denominator, evaluation of results and category)

Name		Numerator	Denominator	Evaluation of results	Category
Quality indicators for the treatment of ovarian carcinoma
1	Surgical staging of early ovarian carcinoma	Primary cases of the denominator with surgical staging with –Laparotomy –Peritoneal cytology –Peritoneal biopsies –Bilateral adnexal extirpation –Hysterectomy; where appropriate, extraperitoneal procedure –Omentectomy at least infracolic –Bilateral pelvic and para-aortal lymphonodectomy	Surgical primary cases ovarian carcinoma FIGO I – IIIA	Plausibility corridor  > 20%	Treatment procedures
2	Macroscopic complete resection of advanced ovarian carcinoma	Surgical primary cases of ovarian carcinoma FIGO llB-IV with macroscopic complete resection	Surgical primary cases with ovarian carcinoma FIGO IIB-IV	Plausibility corridor  > 30% and < 90%	Treatment procedures
3	Surgery of advanced ovarian carcinoma by a gynaecological oncologist	Surgical primary cases of ovarian carcinoma FIGO llB-IV, whose definitive surgical therapy was performed by a gynaeco-oncologist	Surgical primary cases of ovarian carcinoma FIGO llB-IV after conclusion of surgical therapy	Plausibility corridor  > 50%	Process organization
4	Post-operative chemotherapy in advanced ovarian carcinoma	Surgical primary cases of ovarian carcinoma FIGO llB-IV with post-operative chemotherapy	Surgical primary cases of ovarian carcinoma FIGO llB-IV and chemotherapy	Plausibility corridor  > 30%	Treatment procedures
5	First-line chemotherapy for advanced ovarian carcinoma	Primary cases of ovarian carcinoma FIGO llB-IV with six cycles of first-line chemotherapy carboplatin AUC 5 and paclitaxel 175 mg/m.2	Primary cases of ovarian carcinoma FIGO llB-IV	Plausibility corridor  > 20%	Treatment procedures

Name		Numerator	Denominator	Evaluation of results	Category
Quality indicators for the treatment of cervical carcinoma
6	Presentation at the tumour board	Patients (primary cases and ‘non-primary cases’) presented at the tumour board	Patients with an initial diagnosis, recurrence or new remote metastasis of a cervical carcinoma	Plausibility corridor  > 20%	Process organization
7	Details in the pathology report on initial diagnosis and tumour resection	‘Surgical primary cases’ of cervical carcinoma with complete pathology reports with details of Histological type according to WHO Grading Detection/non-detection lymph and vein infiltration (L and V status) Detection/non-detection perineural infiltrates (Pn status) Staging (pTNM and FIGO) in the case of conisated patients, bearing in mind the conisation results Depth of invasion and spread in mm in the case of pT1a1 and pT1a2 Three-dimensional tumour size in centimetres (from pT1b1) Minimum distance to the resection margins	‘Surgical primary cases’ with cervical carcinoma and tumour resection	Plausibility corridor  > 0.01%	Process organization
8	Details in the pathology report for lymphonodectomy	‘Surgical cases’ with a pathology report containing details of The number of affected lymph nodes in relation to removed lymph nodes Assignment to sampling localisation (pelvic/para-aortal) Details of the widest spread of the largest lymph node metastasis in millimetres/centimetres Details of the detection/non-detection of capsule penetration by lymph node metastasis	‘Surgical cases’ with cervical carcinoma and lymphonodectomy	Plausibility corridor  > 0.01%	Process organization
9	Cytological/histological lymph node staging	‘Total cases’ with cytological/histological lymph node staging	‘Total cases’ with cervical carcinoma FIGO stages ≥ IA2–IVA	Plausibility corridor  > 0.01%	Treatment procedures